In a clinical setting, strong immunohistochemical staining of uPA has been significantly correlated to more invasive tumours [48,49] and uPA constitutes a strong, statistically significant independent prognostic marker for shorter disease-free survival [50-52]. This evidence concerns the gene PLAU and neoplasm.